Thioredoxin 80-Activated-Monocytes (TAMs) Inhibit the Replication of Intracellular Pathogens
2011

How Trx80-Activated Monocytes Fight Bacterial Infections

publication 10 minutes Evidence: high

Author Information

Author(s): Cortes-Bratti Ximena, Bassères Eugénie, Herrera-Rodriguez Fabiola, Botero-Kleiven Silvia, Coppotelli Giuseppe, Andersen Jens B., Masucci Maria G., Holmgren Arne, Chaves-Olarte Esteban, Frisan Teresa, Avila-Cariño Javier

Primary Institution: Karolinska Institutet, Stockholm, Sweden

Hypothesis

Trx80-activated monocytes (TAMs) enhance the immune response against intracellular bacterial infections.

Conclusion

Trx80-activated monocytes effectively control the replication of intracellular bacteria like Listeria monocytogenes and Brucella abortus.

Supporting Evidence

  • TAMs inhibit the growth of Listeria monocytogenes and Brucella abortus.
  • Trx80 activation leads to higher expression of CD14 on monocytes.
  • TAMs show enhanced bactericidal activity by preventing bacterial escape from phagosomes.

Takeaway

This study shows that a special type of immune cell, called TAMs, can help our body fight off certain bacteria by keeping them trapped and preventing them from growing.

Methodology

The study involved isolating human monocytes, activating them with Trx80, and then infecting them with Listeria monocytogenes and Brucella abortus to assess bacterial replication.

Participant Demographics

Human peripheral blood mononuclear cells were used, sourced from healthy donors.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016960

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication